The in vitro activity of the new naphthyridone trovafloxacin (CP 99,219) was compared with those of penicillin G and six other agents (cefpodoxime, erythromycin, azithromycin, clindamycin, ciprofloxacin, and sparfloxacin) against 316 penicillin-susceptible and -resistant pneumococci isolated in the former Czechoslovakia. Trovafloxacin was very active against strains of Streptococcus pneumoniae (MIC50 and MIC90 0.25 microgram/ml). Ciprofloxacin was less active (MIC50 1.0 microgram/ml, MIC90 2.0 micrograms/ml), and MICs of sparfloxacin were between those of trovafloxacin and ciprofloxacin (MIC50 and MIC90 both 0.5 microgram/ml). MICs of cefpodoxime, erythromycin, azithromycin, and clindamycin were higher for strains intermediately resistant or resistant to penicillin than for penicillin-susceptible strains.

National Reference Laboratory for Antibiotics National Institute of Public Health Prague Czech Republic

Zobrazit více v PubMed

Clin Infect Dis. 1992 Jul;15(1):119-27 PubMed

Microb Drug Resist. 1995 Spring;1(1):43-8 PubMed

J Antimicrob Chemother. 1995 Jan;35(1):230-2 PubMed

Clin Infect Dis. 1992 Jul;15(1):77-83 PubMed

Clin Microbiol Rev. 1990 Apr;3(2):171-96 PubMed

J Infect Dis. 1995 Jun;171(6):1491-6 PubMed

Microb Drug Resist. 1995 Spring;1(1):71-8 PubMed

J Antimicrob Chemother. 1994 Aug;34(2):191-3 PubMed

In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem